Align Technology Inc (ALGN)
222.43
+4.48 (+2.06%)
USD |
NASDAQ |
Sep 23, 16:00
220.20
-2.23 (-1.00%)
Pre-Market: 08:33
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 17.37B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -69.41% |
| Valuation | |
| PE Ratio | 28.44 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.417 |
| Price to Book Value | 4.827 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 68.51% |
News
Headline
Wire
Time (ET)
MT Newswires
09/15 11:12
Yahoo
09/15 10:30
MT Newswires
09/09 07:28
Yahoo
09/08 12:58
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 10/26/2022* | -- | Results | Q3 2022 | -- | 2.23 | -- | |
| 10/26/2022* | -- | Earnings Call | Q3 2022 | -- | -- | -- | |
| 07/27/2022 | 16:30 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 07/27/2022 | -- | Results | Q2 2022 | 2.00 | 2.23 | -10.16% | |
| 04/27/2022 | -- | Results | Q1 2022 | 2.13 | 2.23 | -4.30% | |
| 04/27/2022 | 16:30 EST | Earnings Call | Q1 2022 | -- | -- | -- | |
| 02/02/2022 | -- | Results | Q4 2021 | 2.83 | 2.73 | 3.79% | |
| 02/02/2022 | 16:30 EST | Earnings Call | Q4 2021 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants). |
| URL | https://www.aligntech.com |
| Investor Relations URL | https://investor.aligntech.com/ |
| HQ State/Province | Arizona |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | Oct. 26, 2022 (est.) |
| Last Earnings Release | Jul. 27, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | -- |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | 0.00 |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | -- |
| Yield (TTM) | 0.00% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of September 23, 2022.
Fundamentals
| Revenue (TTM) | 3.990B |
| Total Expenses (TTM) | 3.121B |
| Net Income (TTM) | 619.03M |
| Total Assets (Quarterly) | 5.810B |
| Total Liabilities (Quarterly) | 2.211B |
| Shareholders Equity (Quarterly) | 3.599B |
| Cash from Operations (TTM) | 785.40M |
| Cash from Investing (TTM) | -511.59M |
| Cash from Financing (TTM) | -478.97M |
Ratings
Profile
Edit
| Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants). |
| URL | https://www.aligntech.com |
| Investor Relations URL | https://investor.aligntech.com/ |
| HQ State/Province | Arizona |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | Oct. 26, 2022 (est.) |
| Last Earnings Release | Jul. 27, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| EGFFX | 542.96M USD | 2.83% |
| FEVR | 537836.0 USD | 2.68% |
| AQGX | 662619.0 USD | 2.28% |
| ARTYX | 78.21M USD | 2.10% |
| KNGS | 144065.0 USD | 1.97% |
| TSNCX | 49.09M USD | 1.80% |
| MRFGX | 69.56M USD | 1.65% |
| DBMCX | 46.17M USD | 1.59% |
| OALC | 844344.0 USD | 1.56% |
| ILDR | 40037.00 USD | 1.43% |
| POLRX | 97.12M USD | 1.01% |
| VFQY | 1.209M USD | 0.70% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| ALGN Tweets |